0,00 €
0
🔥 Metabolic & Fat Loss

Eloralintide

Eloralintide · Long-acting amylin receptor agonist

Eloralintide is an investigational long-acting amylin receptor agonist studied in the context of metabolic and body-weight regulation research.

Type
Amylin receptor agonist
Common sizes
5 mg · 10 mg
Research focus
Metabolic · satiety
Often studied with
Eloralintide · Bioglutide
🧬

What is Eloralintide?

Eloralintide is an investigational peptide designed to activate amylin receptors, which are studied for their role in satiety signalling and glucose regulation. As a long-acting agonist, it is researched in the context of metabolic pathways and energy-balance models, with an emphasis on extended receptor engagement.

Amylin receptor research generally examines effects on gastric signalling, food-intake regulation, and interaction with related metabolic hormone systems. Eloralintide is an emerging investigational compound, and its data is primarily preclinical or early-stage.

🔬

Areas of research

⚖️

Body-weight research

Studied in metabolic models for amylin receptor effects on energy balance and food intake.

🍽️

Satiety signalling

Investigated for potential influence on satiety pathways governed by amylin receptor activation.

🩸

Glucose regulation

Examined for possible effects on glucose handling associated with amylin receptor signalling.

⏱️

Extended action

Researched for prolonged receptor engagement enabled by its long-acting molecular design.

💧

In the lab: reconstitution

1

Bring the vial (5 mg · 10 mg) and bacteriostatic water to room temperature.

2

Add bacteriostatic water slowly along the glass wall — the volume you add sets the concentration.

3

Swirl gently (do not shake) until fully clear, then refrigerate at 2–8 °C.

Tip: The Peptide Calculator converts any vial size and water volume into units per syringe mark automatically.

Full storage & handling guide →

🧩

Commonly researched combinations

🔗

Eloralintide + Bioglutide

Studied together in research combining amylin and GLP-1 receptor pathways for metabolic effects.

View stack →
⚖️

Eloralintide + CJC-1295

Explored in models examining metabolic and growth-axis signalling interactions.

View stack →
📚

Selected research studies

Eloralintide — amylin receptor agonist metabolismPubMed ↗
Eloralintide — amylin satiety signallingPubMed ↗
Eloralintide — long-acting amylin analogPubMed ↗

Links open a PubMed search for the topic. They point to independent literature and are provided for orientation in a research context only.

💬

FAQ

What is Eloralintide?

Eloralintide is an investigational long-acting amylin receptor agonist studied in metabolic research. Amylin receptors are examined for roles in satiety signalling and glucose regulation.

What is it researched for?

It is studied in the context of energy balance, food-intake regulation, and glucose handling in preclinical metabolic models, focusing on amylin receptor activation.

Is Eloralintide approved for use?

No. It is an investigational research compound. It is not an approved therapy, and available data is early-stage. It is intended for laboratory research only.

Explore Eloralintide

See the product, or build a stack around it.

View product →Open Stack-Builder →
For laboratory research only. This guide is provided solely for scientific orientation. Eloralintide and all products are not intended for human or animal use, nor for the diagnosis, treatment or prevention of any disease. Nothing here is dosing guidance.
© Nephiz Labs · Peptide Guide: Eloralintide
Research-use information
Shop
Search
Account
Cart
0
Your Cart (0)
Empty CartYour cart is emptyReturn to Shop
Secure Checkout Secure Checkout
Premium Quality Premium Quality
Fast Shipping Fast Shipping